The Future of Field Excellence – New 2026 report coming soon

Life sciences organizations are redefining what field excellence means as healthcare professional expectations continue to evolve. Traditional engagement models are shifting, and pharmaceutical and biotech companies must rethink how life sciences field teams create value.

Our upcoming Future of Field Excellence Report explores how life sciences organizations are responding to these changes and what it will take to close the gap between ambition and execution.

Building on insights from our 2024 Field Excellence Report, this new research highlights how leading organizations are evolving their field engagement strategies to better support commercial, medical affairs, and market access teams.

Research at a glance

• 100+ life sciences leaders and professionals surveyed
• 54 pharmaceutical and biotech companies represented
• Research conducted across Europe (including the UK and Ireland), the United States, Canada, the Middle East, APAC, and LATAM
• Perspectives from commercial, medical affairs, market access, and learning & development leaders

This global research provides a cross-functional view of how organizations are approaching field excellence in life sciences.

What you’ll learn

This report explores the forces reshaping field engagement in pharma and biotech, including:

• How Organizations Are Redefining Field Excellence
• Capabilities Needed for Modern Field Teams
• Barriers Preventing Field Impact
• Practical Recommendations for Strengthening Field Capabilities

The report also highlights five key trends shaping the future of field engagement across the life sciences industry.